Bio-Rad Laboratories Inc.
BIO | NYSE
$373.02
+$0.84 (+0.23%)
Nov 2, 2026, 12:37 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.58B | 2.57B | 2.67B | 2.8B | 2.92B | 2.55B |
Cost of Revenue | 1.24B | 1.19B | 1.24B | 1.23B | 1.28B | 1.11B |
Gross Profit | 1.34B | 1.38B | 1.43B | 1.57B | 1.64B | 1.44B |
Operating Income | 270.5M | 269M | 337.8M | 482.62M | 500.34M | 421.33M |
Interest Income | 95.5M | 82M | 100.9M | 58M | 18.9M | 18.2M |
Pretax Income | 995.5M | -2.34B | -850.1M | -4.7B | 5.45B | 4.92B |
Net Income | 759.9M | -1.84B | -637.32M | -3.63B | 4.25B | 3.81B |
Selling & General & Admin | 819.9M | 814M | 841.7M | 827.83M | 877.12M | 798.8M |
Research & Development | 256.9M | 295.9M | 247.43M | 256.89M | 260.64M | 217.76M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.08B | 1.11B | 1.09B | 1.08B | 1.14B | 1.02B |
Interest Expense | 49M | 48.9M | 49.44M | 38.11M | 1.55M | 21.86M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.32B | 2.3B | 2.33B | 2.32B | 2.42B | 2.12B |
Income Tax Expense | 235.6M | -498.3M | -212.78M | -1.08B | 1.19B | 1.1B |
Shares Outstanding (Basic) | 27.26M | 28.21M | 29.21M | 29.79M | 29.83M | 29.77M |
Shares Outstanding (Diluted) | 27.28M | 28.21M | 29.21M | 29.79M | 30.21M | 30.16M |
EPS (Basic) | 27.87 | -65.36 | -21.82 | -121.79 | 142.61 | 127.86 |
EPS (Diluted) | 27.87 | -65.36 | -21.82 | -121.79 | 140.83 | 126.20 |
EBITDA | 1.25B | -2.14B | -654.8M | -4.49B | 5.59B | 5.08B |
EBIT | 1.04B | -2.29B | -800.67M | -4.67B | 5.45B | 4.94B |
Depreciation & Amortization | 205.4M | 151.6M | 145.9M | 177.2M | 137.6M | 138.6M |
Add to Watchlist
Select watchlists to add or remove BIO